BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 10600508)

  • 1. Adriamycin inhibits human RH II/Gu RNA helicase activity by binding to its substrate.
    Zhu K; Henning D; Iwakuma T; Valdez BC; Busch H
    Biochem Biophys Res Commun; 1999 Dec; 266(2):361-5. PubMed ID: 10600508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of Gu/RH-II binding protein.
    Valdez BC; Henning D; Perlaky L; Busch RK; Busch H
    Biochem Biophys Res Commun; 1997 May; 234(2):335-40. PubMed ID: 9177271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, cellular localization, and enzymatic activities of RNA helicase II/Gu(beta).
    Valdez BC; Perlaky L; Henning D
    Exp Cell Res; 2002 Jun; 276(2):249-63. PubMed ID: 12027455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
    Perlaky L; Valdez BC; Busch H
    Exp Cell Res; 1997 Sep; 235(2):413-20. PubMed ID: 9299166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping and characterization of the functional domains of the nucleolar protein RNA helicase II/Gu.
    Ou Y; Fritzler MJ; Valdez BC; Rattner JB
    Exp Cell Res; 1999 Mar; 247(2):389-98. PubMed ID: 10066367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle.
    MacCallum DE; Hall PA
    J Pathol; 2000 Apr; 190(5):537-44. PubMed ID: 10727979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the GUCT domain from human RNA helicase II/Gu beta reveals the RRM fold, but implausible RNA interactions.
    Ohnishi S; Pääkkönen K; Koshiba S; Tochio N; Sato M; Kobayashi N; Harada T; Watanabe S; Muto Y; Güntert P; Tanaka A; Kigawa T; Yokoyama S
    Proteins; 2009 Jan; 74(1):133-44. PubMed ID: 18615715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green fluorescent protein tag for studies of drug-induced translocation of nucleolar protein RH-II/Gu.
    Valdez BC; Perlaky L; Cai ZJ; Henning D; Busch H
    Biotechniques; 1998 Jun; 24(6):1032-6. PubMed ID: 9631199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse RNA helicase II/Gu: cDNA and genomic sequences, chromosomal localization, and regulation of expression.
    Valdez BC; Wang W
    Genomics; 2000 Jun; 66(2):184-94. PubMed ID: 10860663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human RNA helicase II/Gu gene: genomic organization and promoter analysis.
    Zhu K; Henning D; Valdez B; Busch H
    Biochem Biophys Res Commun; 2001 Mar; 281(4):1006-11. PubMed ID: 11237763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural domains involved in the RNA folding activity of RNA helicase II/Gu protein.
    Valdez BC
    Eur J Biochem; 2000 Nov; 267(21):6395-402. PubMed ID: 11029582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified human SUV3p exhibits multiple-substrate unwinding activity upon conformational change.
    Shu Z; Vijayakumar S; Chen CF; Chen PL; Lee WH
    Biochemistry; 2004 Apr; 43(16):4781-90. PubMed ID: 15096047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the steric exclusion model for hexameric helicases: substrate features that alter RNA-DNA unwinding by the transcription termination factor Rho.
    Walmacq C; Rahmouni AR; Boudvillain M
    Biochemistry; 2006 May; 45(18):5885-95. PubMed ID: 16669631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein and RNA dynamics play key roles in determining the specific recognition of GU-rich polyadenylation regulatory elements by human Cstf-64 protein.
    Deka P; Rajan PK; Perez-Canadillas JM; Varani G
    J Mol Biol; 2005 Apr; 347(4):719-33. PubMed ID: 15769465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of nucleolar translocation of RNA helicase A.
    Liu Z; Kenworthy R; Green C; Tang H
    Exp Cell Res; 2007 Oct; 313(17):3743-54. PubMed ID: 17822697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effect of anticancer drugs, idarubicin and adriamycin, on soluble chromatin.
    Zahraei Z; Rabbani-Chadegani A
    Eur J Pharmacol; 2007 Dec; 575(1-3):28-33. PubMed ID: 17716648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique epitopes in RNA helicase II/Gu protein recognized by serum from a watermelon stomach patient.
    Garcia MC; Zhou J; Henning D; Arnett FC; Valdez BC
    Mol Immunol; 2000 May; 37(7):351-9. PubMed ID: 11074253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
    J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.